LAMTOR1-PRKCD and NUMA1-SFMBT1 fusion genes identified by RNA sequencing in aneurysmal benign fibrous histiocytoma with t(3;11)(p21;q13)

详细信息    查看全文

• 作者：Ioannis Panagopoulos^a ; ^b ; ^{ioannis.panagopoulos@rr-research.no" class="auth_mail" title="E-mail the corresponding author} ; Ludmila Gorunova^a ; ^b ; Bodil Bjerkehagen^c ; Ingvild Lobmaier^c ; Sverre Heim^a ; ^b ; ^d
• 关键词：Aneurysmal benign fibrous histiocytoma ; cytogenetics ; RNA sequencing ; fusion genes ; LAMTOR1-PRKCD ; NUMA1-SFMBT1
• 刊名：Cancer Genetics
• 出版年：2015
• 出版时间：November 2015
• 年：2015
• 卷：208
• 期：11
• 页码：545-551
• 全文大小：2942 K

文摘

RNA sequencing of an aneurysmal benign fibrous histiocytoma with the karyotype 46,XY,t(3;11)(p21;q13),del(6)(p23)[17]/46,XY[2] showed that the t(3;11) generated two fusion genes: LAMTOR1-PRKCD and NUMA1-SFMBT1. RT-PCR together with Sanger sequencing verified the presence of fusion transcripts from both fusion genes. In the LAMTOR1-PRKCD fusion, the part of the PRKCD gene coding for the catalytic domain of the serine/threonine kinase is under control of the LAMTOR1 promoter. In the NUMA1-SFMBT1 fusion, the part of the SFMBT1 gene coding for two of four malignant brain tumor domains and the sterile alpha motif domain is controlled by the NUMA1 promoter. The data support a neoplastic genesis of aneurysmal benign fibrous histiocytoma and indicate a pathogenetic role for LAMTOR1-PRKCD and NUMA1-SFMBT1.